News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Raleigh Startup Scioderm Nets $9 Million


4/30/2013 8:59:35 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Raleigh startup Scioderm has nabbed $9 million in equity in a recent fundraise. A newly released securities filing shows that the team still has $7 million to go in the round. The dermatological research firm aims to in-license or acquire pharmaceuticals to develop topical products. Its lead candidate, SD-101, aims to treat Epidermolysis Bullosa (EB), an inherited disease that causes painful blisters.

Help employers find you! Check out all the jobs and post your resume.


comments powered by Disqus
Scioderm
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES